Ovarian cancer | Prostate cancer | Rectal cancer | Mammae cancer | ||||||||
Marker: | Ca125 | tPSA(ng/mL) | CEA/(ng/mL) | ||||||||
Clinical diagnose | 87.99 | - | 7.570 | 1.183 | 1.0 | - | - | - | |||
MOCB data | After therapy | After therapy | After therapy | Healthy patient | |||||||
105 bexp | −20.8 | 20.0 | −17.0 | 16.6 | −20.0 | 20.0 | −19.0 | 20.0 | |||
103α(B2)exp | −2.08 | 2.0 | −1.7 | 1.66 | −2.0 | 2.0 | −1.9 | 2.0 | |||
103α(B = 0)exp | 32.18 | 38.15 | 47.28 | 47.53 | 40.21 | 38.35 | 49.00 | 38.96 | |||
10−18 (−)ρ | 3.74 | - | 3.04 | - | 3.60 | - | 3.54 | - | |||
10−18 (+)ρ | - | 3.50 | - | 2.98 | - | 3.50 | - | 3.50 | |||
1051 Sq | 1.35 | - | 1.35 | - | 1.35 | - | 1.35 | - | |||
1034 Rq | - | 2.05 | - | 2.05 | - | 2.05 | - | 2.05 | |||
Enantiomers: | (−) | (+) | (−) | (+) | (−) | (+) | (−) | (+) | |||